Kuangyu Yen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kuangyu Yen has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
Guohuan Sun
School of Biology and Biological Engineering, Southern China University of Technology, Guangzhou, China
3 shared publicationsJin Xu
School of Biology and Biological Engineering, Southern China University of Technology, Guangzhou, China
3 shared publications- Jin Xu
Division of Cell, Developmental and Integrative Biology, School of Medicine, South China University of Technology
3 shared publications Cong Cheng
School of Biology and Biological Engineering, Southern China University of Technology, Guangzhou, China
2 shared publicationsJianyu Yang
Department of Developmental Biology, , , Guangzhou, China
2 shared publicationsShan Liu
School of Biology and Biological Engineering, , Guangzhou, China
2 shared publications
Latest Publications
- Open Access
- 1 February 2022
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 9, 834509
Corrigendum: RUNX1 Upregulates CENPE to Promote Leukemic Cell Proliferation
Corrigendum: RUNX1 Upregulates CENPE to Promote Leukemic Cell Proliferation
- 1 February 2022
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 9, 834509
Open AccessCorrigendum: RUNX1 Upregulates CENPE to Promote Leukemic Cell Proliferation
Corrigendum: RUNX1 Upregulates CENPE to Promote Leukemic Cell Proliferation
- 6 January 2022
- Published by Science China Press., Co. Ltd. in SCIENTIA SINICA Vitae
- Vol. 52 (10) , 1540-1552
QRIS: a machine learning framework to investigate the determinants of retroviral integration specificity
逆转录病毒的活动和多种疾病的发生密切相关,其可通过整合自身基因组到宿主基因组中进行大量有害扩增。与此同时,宿主细胞可根据逆转录病毒的整合位置来启动相关通路抑制其活动。因此整合位点的选择是决定逆转录病毒和宿主命运的关键步骤。尽管国际上已有报道称逆转录病毒在宿主基因组上整合并不随机,并发现了跨逆转录病毒种属的不同DNA基序偏好性,但是这些不足以解释一些基序偏好较弱的逆转录病毒如何获得整合特异性。DNA结构特征,如DNA形状被提出可以影响DNA结合蛋白的与DNA结合的亲和力,但DNA形状对不同逆转录病毒整合的影响机制尚不清楚。本研究通过构建QRIS (Quantify the Retrovirus Integration Specificity) 机器学习框架,定量评估了DNA形状对逆转录病毒整合位点的影响。通过系统地研究跨越四个种属的六种逆转录病毒,本研究发现DNA形状可以独立地或与DNA基序协同地调控逆转录病毒的整合。基于此可将六种逆转录病毒分为三类:“强兼性偏好型”,“弱兼性偏好型”和“强形状偏好型”逆转录病毒。此外本研究发现,即使没有特定偏好的DNA基序,“强形状偏好型”逆转录病毒也可以通过DNA形状获得整合特异性。本文基于机器学习对于大规模逆转录病毒插入位点特性的研究,揭示了DNA结构特征在逆转录病毒致病位点选择中的重要作用。该发现在临床方面为治疗逆转录病毒的策略提供了新靶点和新思路,在应用方面有助于更精确地设计慢病毒载体用于基因编辑和基因治疗。此外,本文建立的机器学习框架也为其他种类病毒的整合特异性研究提供新方法和新视角。
- 6 January 2022
- Published by Science China Press., Co. Ltd. in SCIENTIA SINICA Vitae
- Vol. 52 (10) , 1540-1552
QRIS: a machine learning framework to investigate the determinants of retroviral integration specificity
逆转录病毒的活动和多种疾病的发生密切相关,其可通过整合自身基因组到宿主基因组中进行大量有害扩增。与此同时,宿主细胞可根据逆转录病毒的整合位置来启动相关通路抑制其活动。因此整合位点的选择是决定逆转录病毒和宿主命运的关键步骤。尽管国际上已有报道称逆转录病毒在宿主基因组上整合并不随机,并发现了跨逆转录病毒种属的不同DNA基序偏好性,但是这些不足以解释一些基序偏好较弱的逆转录病毒如何获得整合特异性。DNA结构特征,如DNA形状被提出可以影响DNA结合蛋白的与DNA结合的亲和力,但DNA形状对不同逆转录病毒整合的影响机制尚不清楚。本研究通过构建QRIS (Quantify the Retrovirus Integration Specificity) 机器学习框架,定量评估了DNA形状对逆转录病毒整合位点的影响。通过系统地研究跨越四个种属的六种逆转录病毒,本研究发现DNA形状可以独立地或与DNA基序协同地调控逆转录病毒的整合。基于此可将六种逆转录病毒分为三类:“强兼性偏好型”,“弱兼性偏好型”和“强形状偏好型”逆转录病毒。此外本研究发现,即使没有特定偏好的DNA基序,“强形状偏好型”逆转录病毒也可以通过DNA形状获得整合特异性。本文基于机器学习对于大规模逆转录病毒插入位点特性的研究,揭示了DNA结构特征在逆转录病毒致病位点选择中的重要作用。该发现在临床方面为治疗逆转录病毒的策略提供了新靶点和新思路,在应用方面有助于更精确地设计慢病毒载体用于基因编辑和基因治疗。此外,本文建立的机器学习框架也为其他种类病毒的整合特异性研究提供新方法和新视角。
- Open Access
- 21 December 2021
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9, 723804
Functional Verification of Novel ELMO1 Variants by Live Imaging in Zebrafish
ELMO1 (Engulfment and Cell Motility1) is a gene involved in regulating cell motility through the ELMO1-DOCK2-RAC complex. Contrary to DOCK2 (Dedicator of Cytokinesis 2) deficiency, which has been reported to be associated with immunodeficiency diseases, variants of ELMO1 have been associated with autoimmune diseases, such as diabetes and rheumatoid arthritis (RA). To explore the function of ELMO1 in immune cells and to verify the functions of novel ELMO1 variants in vivo, we established a zebrafish elmo1 mutant model. Live imaging revealed that, similar to mammals, the motility of neutrophils and T-cells was largely attenuated in zebrafish mutants. Consequently, the response of neutrophils to injury or bacterial infection was significantly reduced in the mutants. Furthermore, the reduced mobility of neutrophils could be rescued by the expression of constitutively activated Rac proteins, suggesting that zebrafish elmo1 mutant functions via a conserved mechanism. With this mutant, three novel human ELMO1 variants were transiently and specifically expressed in zebrafish neutrophils. Two variants, p.E90K (c.268G>A) and p.D194G (c.581A>G), could efficiently recover the motility defect of neutrophils in the elmo1 mutant; however, the p.R354X (c.1060C>T) variant failed to rescue the mutant. Based on those results, we identified that zebrafish elmo1 plays conserved roles in cell motility, similar to higher vertebrates. Using the transient-expression assay, zebrafish elmo1 mutants could serve as an effective model for human variant verification in vivo.
- 21 December 2021
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9, 723804
Open AccessFunctional Verification of Novel ELMO1 Variants by Live Imaging in Zebrafish
ELMO1 (Engulfment and Cell Motility1) is a gene involved in regulating cell motility through the ELMO1-DOCK2-RAC complex. Contrary to DOCK2 (Dedicator of Cytokinesis 2) deficiency, which has been reported to be associated with immunodeficiency diseases, variants of ELMO1 have been associated with autoimmune diseases, such as diabetes and rheumatoid arthritis (RA). To explore the function of ELMO1 in immune cells and to verify the functions of novel ELMO1 variants in vivo, we established a zebrafish elmo1 mutant model. Live imaging revealed that, similar to mammals, the motility of neutrophils and T-cells was largely attenuated in zebrafish mutants. Consequently, the response of neutrophils to injury or bacterial infection was significantly reduced in the mutants. Furthermore, the reduced mobility of neutrophils could be rescued by the expression of constitutively activated Rac proteins, suggesting that zebrafish elmo1 mutant functions via a conserved mechanism. With this mutant, three novel human ELMO1 variants were transiently and specifically expressed in zebrafish neutrophils. Two variants, p.E90K (c.268G>A) and p.D194G (c.581A>G), could efficiently recover the motility defect of neutrophils in the elmo1 mutant; however, the p.R354X (c.1060C>T) variant failed to rescue the mutant. Based on those results, we identified that zebrafish elmo1 plays conserved roles in cell motility, similar to higher vertebrates. Using the transient-expression assay, zebrafish elmo1 mutants could serve as an effective model for human variant verification in vivo.
- 1 December 2021
- Published by Elsevier in Journal of Genetics and Genomics
- Vol. 48 (12) , 1081-1090
Chemical screening reveals Ronidazole is a superior prodrug to Metronidazole for nitroreductase-induced cell ablation system in zebrafish larvae
- 1 December 2021
- Published by Elsevier in Journal of Genetics and Genomics
- Vol. 48 (12) , 1081-1090
Chemical screening reveals Ronidazole is a superior prodrug to Metronidazole for nitroreductase-induced cell ablation system in zebrafish larvae
- Open Access
- 9 August 2021
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 8
RUNX1 Upregulates CENPE to Promote Leukemic Cell Proliferation
RUNX1 is a Runt family transcription factor that plays a critical role in normal hematopoiesis, including the differentiation and proliferation of hematopoietic cells. RUNX1 mutations, including chromosomal translocations, cause abnormal cell differentiation, but the mutation alone is not sufficient to cause leukemia. In MLL-fusion-induced leukemia, dysregulated wild-type RUNX1 can promote leukemia survival. Nevertheless, the underlying mechanisms of dysregulated wild-type RUNX1 in leukemia development have not been fully elucidated. This study overexpressed and knocked down RUNX1 expression in THP-1 human leukemia cells and CD34+ hematopoietic stem/progenitor cells to investigate the biological functions affected by dysregulated RUNX1. Our data indicated RUNX1 facilitated proliferation to promote leukemia cell growth. Furthermore, we demonstrated that RUNX1 knockdown in leukemia cells drastically diminished colony-forming ability. Finally, the RUNX1-knocked down cell depletion phenotype could be rescued by overexpression of CENPE, a cell proliferation gene and a RUNX1 direct target gene. Our results indicate a possible mechanism involving the RUNX1-CENPE axis on promoting leukemic cell growth.
- 9 August 2021
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 8
Open AccessRUNX1 Upregulates CENPE to Promote Leukemic Cell Proliferation
RUNX1 is a Runt family transcription factor that plays a critical role in normal hematopoiesis, including the differentiation and proliferation of hematopoietic cells. RUNX1 mutations, including chromosomal translocations, cause abnormal cell differentiation, but the mutation alone is not sufficient to cause leukemia. In MLL-fusion-induced leukemia, dysregulated wild-type RUNX1 can promote leukemia survival. Nevertheless, the underlying mechanisms of dysregulated wild-type RUNX1 in leukemia development have not been fully elucidated. This study overexpressed and knocked down RUNX1 expression in THP-1 human leukemia cells and CD34+ hematopoietic stem/progenitor cells to investigate the biological functions affected by dysregulated RUNX1. Our data indicated RUNX1 facilitated proliferation to promote leukemia cell growth. Furthermore, we demonstrated that RUNX1 knockdown in leukemia cells drastically diminished colony-forming ability. Finally, the RUNX1-knocked down cell depletion phenotype could be rescued by overexpression of CENPE, a cell proliferation gene and a RUNX1 direct target gene. Our results indicate a possible mechanism involving the RUNX1-CENPE axis on promoting leukemic cell growth.
- Open Access
- 22 January 2021
- Published by Springer Nature in Leukemia
- Vol. 35 (8) , 2299-2310
Asxl1 C-terminal mutation perturbs neutrophil differentiation in zebrafish
ASXL1 is one of the most frequently mutated genes in malignant myeloid diseases. In patients with myeloid malignancies, ASXL1 mutations are usually heterozygous frameshift or nonsense mutations leading to C-terminal truncation. Current disease models have predominantly total loss of ASXL1 or overexpressed C-terminal truncations. These models cannot fully recapitulate leukemogenesis and disease progression. We generated an endogenous C-terminal-truncated Asxl1 mutant in zebrafish that mimics human myeloid malignancies. At the embryonic stage, neutrophil differentiation was explicitly blocked. At 6 months, mutants initially exhibited a myelodysplastic syndrome-like phenotype with neutrophilic dysplasia. At 1 year, about 13% of mutants further acquired the phenotype of monocytosis, which mimics chronic myelomonocytic leukemia, or increased progenitors, which mimics acute myeloid leukemia. These features are comparable to myeloid malignancy progression in humans. Furthermore, transcriptome analysis, inhibitor treatment, and rescue assays indicated that asxl1-induced neutrophilic dysplasia was associated with reduced expression of bmi1a, a subunit of polycomb repressive complex 1 and a reported myeloid leukemia-associated gene. Our model demonstrated that neutrophilic dysplasia caused by asxl1 mutation is a foundation for the progression of myeloid malignancies, and illustrated a possible effect of the Asxl1-Bmi1a axis on regulating neutrophil development.
- 22 January 2021
- Published by Springer Nature in Leukemia
- Vol. 35 (8) , 2299-2310
Open AccessAsxl1 C-terminal mutation perturbs neutrophil differentiation in zebrafish
ASXL1 is one of the most frequently mutated genes in malignant myeloid diseases. In patients with myeloid malignancies, ASXL1 mutations are usually heterozygous frameshift or nonsense mutations leading to C-terminal truncation. Current disease models have predominantly total loss of ASXL1 or overexpressed C-terminal truncations. These models cannot fully recapitulate leukemogenesis and disease progression. We generated an endogenous C-terminal-truncated Asxl1 mutant in zebrafish that mimics human myeloid malignancies. At the embryonic stage, neutrophil differentiation was explicitly blocked. At 6 months, mutants initially exhibited a myelodysplastic syndrome-like phenotype with neutrophilic dysplasia. At 1 year, about 13% of mutants further acquired the phenotype of monocytosis, which mimics chronic myelomonocytic leukemia, or increased progenitors, which mimics acute myeloid leukemia. These features are comparable to myeloid malignancy progression in humans. Furthermore, transcriptome analysis, inhibitor treatment, and rescue assays indicated that asxl1-induced neutrophilic dysplasia was associated with reduced expression of bmi1a, a subunit of polycomb repressive complex 1 and a reported myeloid leukemia-associated gene. Our model demonstrated that neutrophilic dysplasia caused by asxl1 mutation is a foundation for the progression of myeloid malignancies, and illustrated a possible effect of the Asxl1-Bmi1a axis on regulating neutrophil development.
- Open Access
- 6 December 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-13
Targeting of apoptosis gene loci by reprogramming factors leads to selective eradication of leukemia cells
Applying somatic cell reprogramming strategies in cancer cell biology is a powerful approach to analyze mechanisms of malignancy and develop new therapeutics. Here, we test whether leukemia cells can be reprogrammed in vivo using the canonical reprogramming transcription factors-Oct4, Sox2, Klf4, and c-Myc (termed as OSKM). Unexpectedly, we discover that OSKM can eradicate leukemia cells and dramatically improve survival of leukemia-bearing mice. By contrast, OSKM minimally impact normal hematopoietic cells. Using ATAC-seq, we find OSKM induce chromatin accessibility near genes encoding apoptotic regulators in leukemia cells. Moreover, this selective effect also involves downregulation of H3K9me3 as an early event. Dissection of the functional effects of OSKM shows that Klf4 and Sox2 play dominant roles compared to c-Myc and Oct4 in elimination of leukemia cells. These results reveal an intriguing paradigm by which OSKM-initiated reprogramming induction can be leveraged and diverged to develop novel anti-cancer strategies.
- 6 December 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-13
Open AccessTargeting of apoptosis gene loci by reprogramming factors leads to selective eradication of leukemia cells
Applying somatic cell reprogramming strategies in cancer cell biology is a powerful approach to analyze mechanisms of malignancy and develop new therapeutics. Here, we test whether leukemia cells can be reprogrammed in vivo using the canonical reprogramming transcription factors-Oct4, Sox2, Klf4, and c-Myc (termed as OSKM). Unexpectedly, we discover that OSKM can eradicate leukemia cells and dramatically improve survival of leukemia-bearing mice. By contrast, OSKM minimally impact normal hematopoietic cells. Using ATAC-seq, we find OSKM induce chromatin accessibility near genes encoding apoptotic regulators in leukemia cells. Moreover, this selective effect also involves downregulation of H3K9me3 as an early event. Dissection of the functional effects of OSKM shows that Klf4 and Sox2 play dominant roles compared to c-Myc and Oct4 in elimination of leukemia cells. These results reveal an intriguing paradigm by which OSKM-initiated reprogramming induction can be leveraged and diverged to develop novel anti-cancer strategies.
- Open Access
- 27 January 2016
- Published by Springer Nature in Nature
- Vol. 530 (7588) , 113-116
Genome-wide nucleosome specificity and function of chromatin remodellers in ES cells
Genome-wide binding profiles for eight different chromatin remodellers in mouse embryonic stem (ES) cells are determined at single nucleosome resolution; each remodeller binds at specific nucleosome positions relative to the start of genes, and the same remodeller acts as a positive or negative regulator of transcription depending on the promoter chromatin organization and epigenetic marking of the gene it binds. The action of chromatin remodeling enzymes is required to allow transcription factors and the general transcription machinery access to DNA. Matthieu Gérard and colleagues determine genome-wide binding profiles for eight different chromatin remodellers in mouse embryonic stem cells at single nucleosome resolution. They find that each remodeller binds at specific nucleosome positions relative to the start of genes, and the same remodeller can act as a positive or negative regulator of transcription depending on the activity of the gene it binds. The findings illustrate how remodellers work together at specific nucleosome positions adjacent to nucleosome-depleted promoter regions in order to regulate transcription. ATP-dependent chromatin remodellers allow access to DNA for transcription factors and the general transcription machinery, but whether mammalian chromatin remodellers1,2,3 target specific nucleosomes to regulate transcription is unclear. Here we present genome-wide remodeller–nucleosome interaction profiles for the chromatin remodellers Chd1, Chd2, Chd4, Chd6, Chd8, Chd9, Brg1 and Ep400 in mouse embryonic stem (ES) cells. These remodellers bind one or both full nucleosomes that flank micrococcal nuclease (MNase)-defined nucleosome-free promoter regions (NFRs), where they separate divergent transcription. Surprisingly, large CpG-rich NFRs that extend downstream of annotated transcriptional start sites are nevertheless bound by non-nucleosomal or subnucleosomal histone variants (H3.3 and H2A.Z) and marked by H3K4me3 and H3K27ac modifications. RNA polymerase II therefore navigates hundreds of base pairs of altered chromatin in the sense direction before encountering an MNase-resistant nucleosome at the 3′ end of the NFR. Transcriptome analysis after remodeller depletion reveals reciprocal mechanisms of transcriptional regulation by remodellers. Whereas at active genes individual remodellers have either positive or negative roles via altering nucleosome stability, at polycomb-enriched bivalent genes the same remodellers act in an opposite manner. These findings indicate that remodellers target specific nucleosomes at the edge of NFRs, where they regulate ES cell transcriptional programs.
- 27 January 2016
- Published by Springer Nature in Nature
- Vol. 530 (7588) , 113-116
Open AccessGenome-wide nucleosome specificity and function of chromatin remodellers in ES cells
Genome-wide binding profiles for eight different chromatin remodellers in mouse embryonic stem (ES) cells are determined at single nucleosome resolution; each remodeller binds at specific nucleosome positions relative to the start of genes, and the same remodeller acts as a positive or negative regulator of transcription depending on the promoter chromatin organization and epigenetic marking of the gene it binds. The action of chromatin remodeling enzymes is required to allow transcription factors and the general transcription machinery access to DNA. Matthieu Gérard and colleagues determine genome-wide binding profiles for eight different chromatin remodellers in mouse embryonic stem cells at single nucleosome resolution. They find that each remodeller binds at specific nucleosome positions relative to the start of genes, and the same remodeller can act as a positive or negative regulator of transcription depending on the activity of the gene it binds. The findings illustrate how remodellers work together at specific nucleosome positions adjacent to nucleosome-depleted promoter regions in order to regulate transcription. ATP-dependent chromatin remodellers allow access to DNA for transcription factors and the general transcription machinery, but whether mammalian chromatin remodellers1,2,3 target specific nucleosomes to regulate transcription is unclear. Here we present genome-wide remodeller–nucleosome interaction profiles for the chromatin remodellers Chd1, Chd2, Chd4, Chd6, Chd8, Chd9, Brg1 and Ep400 in mouse embryonic stem (ES) cells. These remodellers bind one or both full nucleosomes that flank micrococcal nuclease (MNase)-defined nucleosome-free promoter regions (NFRs), where they separate divergent transcription. Surprisingly, large CpG-rich NFRs that extend downstream of annotated transcriptional start sites are nevertheless bound by non-nucleosomal or subnucleosomal histone variants (H3.3 and H2A.Z) and marked by H3K4me3 and H3K27ac modifications. RNA polymerase II therefore navigates hundreds of base pairs of altered chromatin in the sense direction before encountering an MNase-resistant nucleosome at the 3′ end of the NFR. Transcriptome analysis after remodeller depletion reveals reciprocal mechanisms of transcriptional regulation by remodellers. Whereas at active genes individual remodellers have either positive or negative roles via altering nucleosome stability, at polycomb-enriched bivalent genes the same remodellers act in an opposite manner. These findings indicate that remodellers target specific nucleosomes at the edge of NFRs, where they regulate ES cell transcriptional programs.